Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Ecnoglutide in Chinese Participants With Overweight or Obesity
NCT07243171Phase 2Recruiting
- Sponsor
- Sciwind Biosciences
- Start
- Nov 2025
- Primary completion
- Jan 2027
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of ecnoglutide in obesity, sponsored by Sciwind Biosciences. Started Nov 2025; status: recruiting.
02
Drugs
ecnoglutide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07243171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07243171.